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Measurement of Japanese Cedar
Pollen-Specific IgE in Nasal Secretions
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ABSTRACT
Background: Japanese cedar pollen (JCP) is the most common allergen for seasonal allergic rhinitis in Ja-
pan. Little is known about local production of immunoglobulin (Ig)E in people with or without Japanese cedar
pollinosis. The aims of this study were to measure levels of JCP-specific IgE in nasal secretions and determine
correlations with levels in serum.
Methods: Forty-six subjects were enrolled in this study, comprising 24 symptomatic subjects, 9 asymptomatic
subjects sensitized to JCP, and 13 subjects not sensitized to JCP. Nasal secretions were obtained during a pe-
riod of Japanese cedar dispersal, and levels of JCP-specific IgE were measured with CAP-fluorescent enzyme
immunoassay. Serum JCP-specific IgE and total IgE were also measured using the same method.
Results: Among the 46 subjects enrolled, JCP-specific IgE in nasal secretions was measureable in 43 sub-
jects. Irrespective of symptom development, sensitized subjects showed higher levels of JCP-specific IgE in
nasal secretions than non-sensitized subjects. A significant moderate correlation was observed between JCP-
specific IgE levels in nasal secretions and serum in all 43 subjects. With stratification by subject group, only
symptomatic subjects showed a substantial correlation between JCP-specific IgE levels in nasal secretions and
serum.
Conclusions: Our results imply a certain association between JCP-specific IgE in nasal secretions and sensi-
tization of Japanese cedar pollinosis. Therefore, levels of allergen-specific IgE in nasal secretions can be used
as an alternative diagnostic marker for allergic rhinitis patients.
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INTRODUCTION
Allergic rhinitis (AR) is an immunoglobulin (Ig)E-
mediated inflammatory disease of the nasal mucosa
resulting from exposure to an inhalant allergen. IgE
plays an important role in the development of AR.
One of the ways to determine the presence of sensiti-
zation to allergens is to measure allergen-specific IgE
levels in serum, and this approach is used widely in
daily practice. Many studies have detected IgE not
only in serum, but also in nasal secretions in patients
with AR,1,2 showing local production of IgE in the na-
sal mucosa. Recent research has shown local produc-
tion of IgE in patients who are negative for serum
IgE, leading to the concept of local AR.3-8 Local IgE
production is thought to play a more important role
than IgE in the serum in allergic inflammation.
The origin of allergen-specific IgE in nasal secre-
tions has been addressed by many studies. In pa-
tients with AR, allergen-specific IgE is detected in na-
sal mucosa9 in addition to nasal secretions.2 More-
over, somatic hypermutation and class switching to
IgE have been observed in the nasal mucosa in pa-
tients with AR,10 suggesting that locally detected IgE
is produced in nasal mucosa rather than a mere tran-
sudate from serum. Until recently, the major sources
and sites of allergen-specific IgE production have not
been fully identified. However, a recent study showed
that the majority of allergen-specific IgE in peripheral
blood is not derived from IgE-secreting cells in the
blood, suggesting local IgE production in tissues as a
major source of allergen-specific IgE.11 Given such
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findings, allergen-specific IgE in both nasal secre-
tions and serum may be derived from common sites
of production.
Allergens vary from one region to another. In Ja-
pan, Japanese cedar pollen (JCP) from Cryptomeria
japonica represents the most common allergen for
seasonal AR, affecting more than 30% of the popula-
tion as Japanese cellar pollinosis, and the morbidity
rate has been rising.12 Despite many clinical and ba-
sic investigations into Japanese cellar pollinosis, little
is known about local production of IgE in individuals
with or without Japanese cedar pollinosis. No stan-
dardized method for quantitative measurement of IgE
in nasal secretions is clinically available. Further-
more, the correlation between concentrations of IgE
in serum and in nasal secretions has not been eluci-
dated. The aims of this study were both to measure
JCP-specific IgE in nasal secretions using a clinically
available method and to evaluate correlations with its
serum counterpart in subjects with or without Japa-
nese cedar pollinosis.
METHODS
STUDY SUBJECTS
A total of 46 subjects (age range, 1-78 years) with or
without Japanese cedar pollinosis were recruited in
the present study. These included healthy subjects as
well as patients who were under treatment for various
diseases in the outpatient clinic of our department.
Patients with chronic rhinosinusitis were excluded
from this study.
STUDY DESIGN
The study was performed from January to March
2012, during a period of JCP dispersal in Japan.
Symptoms associated with allergic rhinitis and levels
of JCP-specific IgE in both serum and nasal secre-
tions were evaluated. Medication was not restricted
for subjects in this study. During the study period,
subjects took medications as usual for their underly-
ing medical conditions, including Japanese cedar pol-
linosis.
Subjects were classified into the following 3 groups
according to sensitization to JCP and presence of
symptoms of Japanese cedar pollinosis: Group 1,
which included symptomatic subjects who were sen-
sitized to JCP; Group 2, which included asymptomatic
subjects who were sensitized to JCP; and Group 3,
which included asymptomatic subjects who were not
sensitized to JCP. The presence of Japanese cedar
pollinosis was defined as development of typical
symptoms affecting the nose and eyes during JCP
dispersal and eosinophilia in nasal secretions. Sensiti-
zation was defined as serum JCP-specific IgE levels
0.70 kUAmL (IgE ImmunoCAP class2).
This study was approved by the ethics committee
of Mie University. Written informed consent was ob-
tained from all subjects and parents or guardians of
subjects under 20 years old.
PREPARATION OF NASAL SECRETIONS FOR
SPECIFIC IgE MEASUREMENT
Nasal secretions were obtained using an ATOMS
tapⓇ (Lumenis, Tokyo, Japan). The ATOMS tapⓇ is a
device originally designed for collecting middle ear
effusion for the diagnosis of otitis media. The instru-
ment is equipped with a suction tip about 2 mm in di-
ameter and 60 mm in length, and a bottle into which
the aspirated sample is collected. The tip was in-
serted into the nasal cavity of subjects to aspirate na-
sal secretions. The obtained nasal secretions were
frozen at -20℃ until analysis. After thawing, the nasal
secretions were diluted with 0.05 M phosphate saline
buffer. Samples were centrifuged for 5 min, and su-
pernatants were collected for measurement of IgE.
MEASUREMENT OF TOTAL AND SPECIFIC IgE
TITERS OF SERUM AND NASAL SECRETIONS
Levels of JCP-specific IgE in nasal secretions and se-
rum were measured with CAP-fluorescent enzyme
immunoassay (FEIA) (Phadia, part of Thermo Fisher
Scientific, Tokyo, Japan) in the same manner used in
daily practice. Total IgE in serum was also measured
this way.
SPIKE AND RECOVERY TESTS
Nasal secretion contains many substances including
IgA and mucin, which may interfere with the assay.
To validate and assess the accuracy of the assay,
spike and recovery tests were performed as follows.
Among the set of the samples of nasal secretions pre-
served, 4 samples whose concentrations of JCP-
specific IgE had been determined below 0.1 UmL
were selected and thawed. The concentrations of IgE
of the samples were measured and found to be identi-
cal to those measured before preservation. A human
serum containing high concentration of IgE was used
as a spiking solution. The spiking solution was added
to each sample at 1 : 10 dilution. The spiking solution
was also added to the standard diluent (0.05 M phos-
phate saline) at the same dilution. The standard di-
lute has been proven not to interfere with the assay.
The concentrations of IgE in each spiked sample and
the spiked standard diluent were determined. The re-
covery rate was calculated as the ratio of the value of
each spiked sample to that of the spiked standard di-
lute.
LINEARITY OF DILUTION TESTS
Among the set of the samples of nasal secretions, a
sample with high concentration of JCP specific IgE
was selected. The sample was serially diluted with
the standard dilute to make dilution 1 : 2, 1 : 4, 1 : 8,
and 1 : 16. The concentrations of IgE in each diluted
sample were measured. The recovery rate was calcu-
lated as the ratio of measured values at each dilution
IgE in Nasal Secretions
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Table　1　Epidemiological and laboratory data of study subjects
Group Group 1 Group 2 Group 3
Subjects enrolled (n) 24 9 13
Subjects analyzed (n) 23 8 12
Age 49 ± 16 34 ± 11 48 ± 22
Sex, n (%)
 Male 13 (57%) 3 (38%) 5 (42%)
 Female 10 (43%) 5 (62%) 7 (58%)
IgE
 Positive detection rate 78%† 63% 17%
 JCP in nasal secretions (kUA/mL) 4.9 ± 9.9† 0.50 ± 0.51 0.20 ± 0.49
 JCP in serum (kUA/mL) 25 ± 28† 9.1 ± 9.0‡ 0.3 ± 1.3 × 10−7
 Total IgE in serum (kU/mL) 247 ± 392 119 ± 93 79.0 ± 90.4
Data are expressed as mean ± standard deviation.
JCP, Japanese cedar pollen; JCP in nasal secretions, IgE specifi c to JCP in nasal secretion; JCP in serum, IgE specifi c to JCP in serum.
†Signifi cant difference between Groups 1 and 3. ‡Signifi cant difference between Groups 2 and 3.
to the expected values deduced based on the given
respective dilution. A linear regression analysis was
carried out to determine the extent of the relationship
between the measured values and the expected val-
ues.
STATISTICAL ANALYSIS
Spearman’s rank correlation coefficient was used to
evaluate correlation between two sets of variables.
Data among the 3 groups were compared using the
Kruskal-Wallis test. If a significant difference was
found, post-hoc comparisons were carried out by the
Mann-Whitney U test with Bonferroni’s correction.
The chi-square test was used to examine differences
with categorical variables. Values of P < 0.05 were
considered significant. All statistical analyses were
carried out using JMP version 5.1.1 software (SAS In-
stitute, Cary, NC, USA).
RESULTS
SUBJECTS
The 46 subjects comprised 22 males and 24 females,
with 24 subjects in Group 1, 9 in Group 2, and 13 in
Group 3.
SUBJECT CHARACTERISTICS AND LABORA-
TORY DATA
Table 1 shows the details of subject characteristics
and all data concerning IgE. Of the 46 samples of na-
sal secretions obtained from 46 subjects, levels of
JCP-specific IgE were successfully measured in 43.
Measurement was technically impossible in remain-
ing 3 samples due to excessively high viscosity, and
these 3 subjects were subsequently eliminated from
the analysis. As a result, Groups 1, 2, and 3 included
23, 8, and 12 subjects, respectively. No complications
were seen in any subjects during the collection of na-
sal secretions. Of the 43 samples successfully meas-
ured, JCP-specific IgE was detected in 58%. Detection
rates in each group were 78%, 63%, and 17% for
Groups 1, 2, and 3, respectively.
Levels of JCP-specific IgE in nasal secretions were
then compared among the 3 groups (Fig. 1). Group 1
showed significantly higher levels of JCP-specific IgE
in nasal secretions than Group 3; however, no signifi-
cant difference was observed between Groups 1 and
2. Additionally, no significant difference was observed
between Groups 2 and 3. Levels of JCP-specific IgE in
serum were also compared among the 3 groups.
Groups 1 and 2 each showed significantly higher se-
rum levels of JCP-specific IgE than Group 3, but no
significant difference was observed between Groups
1 and 2. Additionally, no significant difference was ob-
served in total IgE among the 3 groups (Table 1).
CORRELATIONS BETWEEN JCP-SPECIFIC IgE
IN NASAL SECRETIONS AND JCP-SPECIFIC
AND TOTAL IgE IN SERUM
A significant moderate association was observed be-
tween JCP-specific IgE in nasal secretions and JCP-
specific IgE in serum overall for the 43 subjects (r =
0.79, P < 0.001) (Fig. 2A). When all data were strati-
fied by subject group and analyzed separately, a sig-
nificant positive correlation was observed only for
Group 1 (r = 0.78, P < 0.001) (Fig. 2B). No significant
correlations were seen for Groups 2 and 3 (Fig. 2C,
D). A similar significant moderate association was ob-
served between JCP-specific IgE in nasal secretions
and total IgE in serum in all 43 subjects (r = 0.65, P <
0.001).
SPIKE AND RECOVERY TESTS
The recovery rates of each sample were 102%, 105%,
108%, and 109%.
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Fig.　1　Comparison of JCP-specifi c IgE levels in nasal secretions among the 3 
groups. Individual data are shown. Since the majority of values from the 3 groups 
were clumped at the bottom of the graph when data were shown on a linear scale, 
data are shown on a logarithmic scale to make the graph more understandable. 
Each dot is shown if its value is greater than zero, because zero cannot be shown 
on the log scale. Horizontal bars represent means for each group. *P < 0.005.
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LINEARITY OF DILUTION TESTS
The recovery rates of each sample at dilution of 1 : 2,
1 : 4, 1 : 8, and 1 : 16 were 106%, 106%, 110%, and 119%
respectively. Adjusted coefficient of determination
was 0.999 and the equation obtained was: y = 0.159 +
1.04x, where y was the measured values and x was
expected values. Coefficient correlation was 0.999
and P-value was below 0.001.
DISCUSSION
This study was intended to measure allergen-specific
IgE in nasal secretions in patients with allergic rhini-
tis caused by JCP. It had two major findings. First,
JCP-specific IgE was detected in most symptomatic
subjects and in more than half of asymptomatic but
sensitized subjects, and levels of JCP-specific IgE
both in nasal secretions and in serum correlated sig-
nificantly in symptomatic subjects. Second, nasal se-
cretions were able to be obtained easily and safely us-
ing a simple suctioning and collection device.
JCP-specific IgE was detected in most Group 1
(symptomatic) subjects. Previous studies have de-
tected allergen-specific IgE in nasal secretions in pa-
tients with AR induced by several aeroaller-
gens.1,2,13,14 The high detection rate of JCP-specific
IgE in nasal secretions from symptomatic patients in
our study was consistent with those results. In addi-
tion, our study showed that 63% of Group 2, which
represented asymptomatic but sensitized subjects,
had JCP-specific IgE in nasal secretions. To the best
of our knowledge, analysis of allergen-specific IgE in
nasal secretions from asymptomatic sensitized sub-
jects has not been reported previously. Furthermore,
although levels were quite low, a small portion of
Group 3, representing asymptomatic and non-
sensitized subjects, also showed positive IgE in nasal
secretions. A possible explanation for this observa-
tion in Group 3 is that JCP-specific IgE may have
been present in serum at levels below the threshold
of detection. Another possibility is production of JCP-
specific IgE only in the nasal mucosa. However, no
definite explanation for this observation can be
drawn.
A significant moderate correlation between the
level of allergen-specific IgE in nasal secretions and
that in serum was observed for the overall subject
population in our study. With stratification by subject
group, only Group 1 showed a significant correlation,
representing a novel finding in this field. The overall
correlation might be attributable to the high correla-
tion in Group 1, particularly since Group 1 included
53% of all subjects. Generally, quantitative specific
IgE levels in serum have been shown to be useful in
predicting the probability of AR, and specific IgE se-
rum concentration is associated with symptom sever-
ity in children with seasonal AR.15 Our data imply the
possible utility of measuring allergen-specific IgE in
nasal secretion as an alternative diagnostic biomarker
of allergen-specific IgE in serum. On the other hand,
although JCP-specific IgE was detected from nasal se-
IgE in Nasal Secretions
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Fig.　2　Correlation between JCP-specifi c IgE in nasal secretions and serum in all subjects and 
within each group. A) All subjects; B) Group 1; C) Group 2; D) Group 3. P values are shown. Val-
ues for the coefficient of correlation and trend lines are displayed for statistically signifi cant corre-
lations. In Graph D, six dots with values of 0 on the X-axis and 0.34 on the Y-axis overlapped ex-
actly; these dots are jittered slightly for the purposes of depiction.
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cretions in 63% of subjects in Group 2, no significant
correlation was seen between the level of JCP-specific
IgE in nasal secretions and that in serum. It is possi-
ble to make a speculative hypothesis as follows on the
basis of those observations: JCP-specific IgE is se-
creted into nasal secretions at a certain concentration
if a patient is sensitized to JCP. After developing
symptoms of AR, much more JCP-specific IgE is re-
leased into nasal secretions, reaching a level corre-
sponding to the level in serum. Since our study was
conducted on a practical clinical basis, detailed cellu-
lar and molecular mechanisms are beyond the reach
of this study.
Second, nasal secretions were obtained easily and
safely using a simple suctioning and collection de-
vice, the ATOMS tapⓇ. Unlike measurement of
allergen-specific IgE in serum, standard methods for
collecting nasal secretions and measuring levels of
allergen-specific IgE in nasal secretions have yet to
be established. Several methods have been employed
in the literature to detect IgE in nasal secretions. For
instances, some authors have collected nasal secre-
tions by nasal lavage,7 while others have employed a
device using the allergen-coupled cellulose derivative
for measurement of IgE.13,14 We used the ATOMS
tapⓇ in the present study to obtain nasal secretions.
The ATOMS tapⓇ is a device originally designed for
collecting middle ear effusion for the diagnosis of oti-
tis media and has received formal approval for use as
a medical device in Japan. By simply connecting the
unit to a conventional suction device, it is instantly
ready for use. The tip is thin enough to be inserted
into a congested nasal cavity or the narrow nasal cav-
ity of a child. No prior steps are needed before col-
lecting nasal secretions. The device enables rapid and
convenient collection of nasal secretions and is appli-
cable even for children.
We were able to obtain measurements for almost
all samples, with the exception of 3 exceptionally vis-
cous samples. The methodology used in this study is
applicable to daily clinical practice. Another advan-
tage of our method is the ability to measure allergen-
specific IgE among the wide IgE repertoire offered
by clinical laboratories. The CAP- immunoassay is
the test designed and validated to measure allergen-
specific IgE in the serum. Unlike the serum, nasal se-
cretion contains many substances including IgA and
mucin. These substances may interfere with the as-
say and may affect the results. Spike and recovery
tests demonstrated that the assay was not affected
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the matrices of nasal secretions. Linearity of dilution
tests proved the linearity of the assay. We believe that
these two tests validated the accuracy of the assay in
our study. Currently, possible clinical implications of
measuring local IgE in nasal secretions include the
measurement of specific IgEs from children, from
whom collection of a blood sample can be difficult.
Moreover, our methodology may contribute to fur-
ther investigation of local IgE by providing a useful
tool to obtain nasal secretions. However, the repro-
ducibility and repeatability of our measurement
method have not been confirmed, and additional fun-
damental studies are needed to validate the present
approach.
The significance of local IgE in AR has yet to be in-
vestigated. Practical Guideline for the Management
of Allergic Rhinitis in Japan16 do not mention local
IgE, and it is not currently used as an examination for
AR.17,18 Moreover, the Allergic Rhinitis and its Impact
of Asthma (ARIA) criteria issued in 2008 refers to
nasal-specific IgE and states that, based on current
data, the concept of local allergic reaction in the nose
without systemic IgE release is not fully supported
and the measurement of IgE in nasal secretions can-
not be routinely proposed. However, a growing num-
ber of articles have addressed local IgE in AR. A diag-
nostic flow-chart to detect forms of allergy different
from the common IgE-mediated hypersensitivity, and
incorporating local IgE, has been proposed.19
Some limitations must be considered when inter-
preting the present results. Measurement of allergen-
specific IgE in nasal secretions and serum was car-
ried out only once during the study period. In sea-
sonal AR, levels of allergen-specific IgE in serum de-
pend on the amount of allergen to which the patient
has been exposed.20,21 Our result might depict only
part of the phenomenon, not the entire situation. Ide-
ally, repeated measurement of allergen-specific IgE in
both serum and nasal secretions over the year seems
necessary to accurately evaluate the association be-
tween levels in these different compartments. Since
the number of enrolled subjects was too small to
reach a definitive conclusion, larger-scale studies are
needed to confirm our result.
In conclusion, we measured JCP-specific IgE in the
nasal secretions of subjects with and without Japa-
nese cedar pollinosis using a novel methodology. A
significantly high correlation was observed between
levels of IgE in nasal secretions and in serum in
symptomatic subjects. Although the current under-
standing of local IgE is insufficient and much remains
to be studied, our data might offer some contribu-
tions and clinical implications regarding local IgE in
AR.
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